Literature DB >> 12768442

Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women.

Hye Won Chung1, Jeong-Sun Seo2, Sung Eun Hur1, Hyung Lae Kim3, Jun Yeon Kim4, Ji Hyun Jung4, Lyoung Hyo Kim4, Byung Lae Park4, Hyoung Doo Shin4.   

Abstract

Interleukin-6 (IL6) has many roles essential to the regulation of the immune response, hematopoiesis, and bone resorption. Three single-nucleotide polymorphisms (SNP) in the IL6 promoter region were genotyped by the single-base extension method. The frequencies of each SNP were 0.002 ( IL6-597 G--> A), 0.27 ( IL6-572 G--> C), and 0.002 ( IL6-174 G--> C) in a Korean population ( n=1,082). IL6-597 G--> A and IL6-174 G--> C were totally linked together ( d(2)=1) and showed very low allele frequencies (0.002), which are common in Caucasians. On the other hand, the frequency of the IL6-572 G--> C*C allele was much higher (0.27) than that in Caucasian populations (<0.07). One of the IL6 promoter SNPs, viz., IL6-572 G--> C, showed significant associations with bone mineral density (BMD), i.e., the C allele was associated with increased BMD ( P=0.02, co-dominant model; P=0.007, dominant model). The mean BMD was highest in homozygous C individuals (0.67+/-0.15), lowest in homozygous G individuals (0.58+/-0.19), and intermediate in heterozygotes (0.64+/-0.21). In the present study, we describe a variant in the IL6 promoter region that shows positive association with higher BMD in a gene-dose-dependent manner in pre-menopausal women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768442     DOI: 10.1007/s10038-003-0020-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  38 in total

1.  A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.

Authors:  N Ota; T Nakajima; I Nakazawa; T Suzuki; T Hosoi; H Orimo; S Inoue; Y Shirai; M Emi
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Estimating African American admixture proportions by use of population-specific alleles.

Authors:  E J Parra; A Marcini; J Akey; J Martinson; M A Batzer; R Cooper; T Forrester; D B Allison; R Deka; R E Ferrell; M D Shriver
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

3.  Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis.

Authors:  Y V Ho; E M Briganti; Y Duan; R Buchanan; S Hall; E Seeman
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Relation of polymorphism in the promotor region for the human osteocalcin gene to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.

Authors:  H Y Chen; H D Tsai; W C Chen; J Y Wu; F J Tsai; C H Tsai
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

5.  The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis.

Authors:  M Fedetz; F Matesanz; M Pascual; J Martín; O Fernández; M Guerrero; A Alcina
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

6.  Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP.

Authors:  S S Papiha; L C Allcroft; R M Kanan; R M Francis; H K Datta
Journal:  Calcif Tissue Int       Date:  1999-10       Impact factor: 4.333

7.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Authors:  G Poli; A L Kinter; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Authors:  A Papassotiropoulos; M Bagli; F Jessen; T A Bayer; W Maier; M L Rao; R Heun
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

9.  [Genetic polymorphism of vitamin D receptor and osteoporosis].

Authors:  M Sosa Henríquez; A Torres Ramírez; C Domínguez Cabrera; E Salido; P Saavedra Santana; Y Barrios; J M Limiñana Cañal; P Betancor León
Journal:  Med Clin (Barc)       Date:  1998-05-16       Impact factor: 1.725

10.  Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women.

Authors:  J Taboulet; M Frenkian; J L Frendo; N Feingold; A Jullienne; M C de Vernejoul
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

View more
  26 in total

1.  Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus.

Authors:  Chung-Ming Huang; An-Ping Huo; Chang-Hai Tsai; Chi-Lan Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Wei-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 3.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation.

Authors:  M Müller-Steinhardt; B Ebel; C Härtel
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 5.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 6.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

7.  Clinical relevance of IL-6 gene polymorphism in severely injured patients.

Authors:  Vasilije Jeremić; Tamara Alempijević; Srđan Mijatović; Ana Sijački; Sanja Dragašević; Sonja Pavlović; Biljana Miličić; Slobodan Krstić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

Review 8.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

9.  Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease.

Authors:  Mei-xia He; Wan-li Yang; Ming-ming Zhang; Ya-jun Lian; Hai-ying Hua; Jin-sheng Zeng; Li-rong Zhang
Journal:  Neurol Sci       Date:  2009-12-03       Impact factor: 3.307

10.  Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.

Authors:  Deanna S Cross; Lynn C Ivacic; Elisha L Stefanski; Catherine A McCarty
Journal:  BMC Genet       Date:  2010-06-17       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.